Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2010-2-22
pubmed:abstractText
To assess whether treatment with statins or renin-angiotensin-aldosterone system (RAAS) inhibitors as potential procedural 'augmenting agents' improved atrial fibrillation (AF) catheter ablation recurrence rates in post-menopausal females (PMFS).
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1532-2092
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
322-30
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:20064822-Aged, pubmed-meshheading:20064822-Angiotensin II Type 1 Receptor Blockers, pubmed-meshheading:20064822-Atrial Fibrillation, pubmed-meshheading:20064822-C-Reactive Protein, pubmed-meshheading:20064822-Catheter Ablation, pubmed-meshheading:20064822-Combined Modality Therapy, pubmed-meshheading:20064822-Female, pubmed-meshheading:20064822-Follow-Up Studies, pubmed-meshheading:20064822-Humans, pubmed-meshheading:20064822-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:20064822-Kaplan-Meier Estimate, pubmed-meshheading:20064822-Middle Aged, pubmed-meshheading:20064822-Postmenopause, pubmed-meshheading:20064822-Postoperative Complications, pubmed-meshheading:20064822-Predictive Value of Tests, pubmed-meshheading:20064822-Proportional Hazards Models, pubmed-meshheading:20064822-Recurrence, pubmed-meshheading:20064822-Renin-Angiotensin System, pubmed-meshheading:20064822-Risk Factors, pubmed-meshheading:20064822-Treatment Outcome
pubmed:year
2010
pubmed:articleTitle
The impact of statins and renin-angiotensin-aldosterone system blockers on pulmonary vein antrum isolation outcomes in post-menopausal females.
pubmed:affiliation
St David's Medical Center, Texas Cardiac Arrhythmia Institute, Austin, TX, USA.
pubmed:publicationType
Journal Article, Controlled Clinical Trial